CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in two upcoming investor conferences.

30^th Annual Piper Jaffray Healthcare Conference in New York City

• Peter Maag will present on Wednesday, November 28^th at 1:00 PM ET

Evercore ISI HealthCONx Conference in Boston

• Peter Maag will present on Thursday, November 29^th at 8:45 AM ET

Live audio webcasts of the 30^th Annual Piper Jaffray Healthcare Conference and Evercore ISI HealthCONx Conference presentations will be available online from the investor relations section of the CareDx website at http://investors.caredx.com. The webcast replay of the presentations will be available approximately one hour following the conclusion of the live presentation and will be available on the Company’s website for 90 days.

About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum.

For more information, please visit: www.CareDx.com.

CONTACTS:
Investor Relations
David Clair
Integrated Corporate Relations, Inc.
646-277-1266
david.clair@icrinc.com